CNE100003NX4
CNE100003NX4
SHANGHAI HAOHAI BIOLOGICAL TECH
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.446.306.000 | 2.679.667.000 | 8.7% |
| Cost of Revenue | 734.729.000 | 810.879.000 | 9.4% |
| Gross Profit | 1.711.577.000 | 1.868.788.000 | 8.4% |
| 1.394.448.000 | 1.422.594.000 | 2.0% | |
| Operating Income | 317.129.000 | 446.194.000 | 28.9% |
| Pretax Income | 239.246.000 | 466.145.000 | 48.7% |
| Net Income Common Stockholders | 251.009.000 | 420.447.000 | 40.3% |
| -- | -- | -- | |
| -- | -- | -- |